Journals / Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi / 2026 / Volume: 13 Issue: 1

Heart Failure Symptoms and the Relationship Between the Symptoms and Quality of Life: A Cross-Sectional, Correlational Study

Kalp Yetersizliği Semptomları ve Semptomlar ile Yaşam Kalitesi Arasındaki İlişki: Kesitsel ve İlişkisel Bir Çalışma

Zöhre Irmak(Muğla Sıtkı Koçman Üniversitesi,)0000-0003-1941-8768
Volkan Doğan(MUGLA SITKI KOCMAN UNIVERSITY)0000-0003-1836-2846
Özcan Başaran(MUGLA SITKI KOCMAN UNIVERSITY)0000-0002-6384-6455
Derya Demir Uysal(MUGLA SITKI KOCMAN UNIVERSITY)0000-0002-7883-6292
Pages
—
Publication Date
2026-04-29
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Applying self-care and other intervention strategies can contribute to easing symptoms and improving quality of life and other patient outcomes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diagnosis of symptoms and elucidating their association with quality of life in patients with heart failure may contribute to more effective symptom management and enhancement of quality of life.
📊
Key Findings & Data:This cross-sectional and correlational study was conducted with a convenience sample of 242 patients in a training and research hospital.
💡
Conclusion & Impact:Applying self-care and other intervention strategies can contribute to easing symptoms and improving quality of life and other patient outcomes.
🔬Design:Survey & Empirical Study
📍Scope:Comprehensive Sample
⚙️Variables:Heart Failure · Symptoms · Quality of Life

Abstract

Diagnosis of symptoms and elucidating their association with quality of life in patients with heart failure may contribute to more effective symptom management and enhancement of quality of life. This study aimed to examine symptoms of the patients with heart failure and the relationship between the symptoms and quality of life. This cross-sectional and correlational study was conducted with a convenience sample of 242 patients in a training and research hospital. Data were collected using the Memorial Symptom Assessment Scale-Heart Failure (MSAS-HF) and the Minnesota Living With Heart Failure Questionnaire (MLHFQ). Descriptive statistics and hierarchical linear multiple regression analysis were used for data analysis. The mean prevalence of the symptoms experienced by the patients was 15.14±6.52. The physical symptoms with the highest prevalence and burden were fatigue, difficulty breathing when lying flat, and shortness of breath, while the psychological symptoms with the highest prevalence and burden were nervousness, uneasiness, and anxiety. The physical and psychological symptoms were found to have a significant relationship with the total (p< 0.001; p=0.026, respectively) and physical (p< 0.001; p=0.004, respectively) quality of life. However, the physical symptoms were not found to be significantly related to the emotional quality of life (p=0.156). The prevalence and burden of symptoms are high among patients with heart failure, and both physical and psychological symptoms have a significant relationship with total quality of life. Applying self-care and other intervention strategies can contribute to easing symptoms and improving quality of life and other patient outcomes.

Özet

Kalp yetersizliği hastalarında semptomların tanılanması ve yaşam kalitesi ile ilişkisinin belirlenmesi, etkili semptom yönetimine ve yaşam kalitesinin iyileştirilmesine katkı sağlayabilir. Bu çalışma, kalp yetersizliği hastalarının semptom prevalansını ve semptomlarının yaşam kalitesi ile ilişkisini incelemeyi amaçlamıştır. Bu kesitsel ve ilişkisel çalışma, bir eğitim ve araştırma hastanesinde 242 hastadan oluşan örneklem ile yapıldı. Veriler, Memorial Semptom Değerlendirme Ölçeği- Kalp Yetersizliği ve Minnesota Kalp Yetersizliği ile Yaşam Anketi kullanılarak toplandı. Verilerin analizinde tanımlayıcı istatistik ve hiyerarşik çoklu doğrusal regresyon analizi kullanıldı. Hastaların deneyimledikleri semptomların prevalans ortalaması 15.14±6.52 idi. Prevalansı ve yükü en fazla olan fiziksel semptomlar halsizlik, yatar pozisyonda solunum sıkıntısı ve solunum sıkıntısı iken, prevalansı ve yükü en fazla olan psikolojik semptomların ise sinirlilik, huzursuzluk ve kaygı olduğu belirlendi. Fiziksel ve psikolojik semptomların total (sırasıyla, p<0.001; p=0.026) ve fiziksel (sırasıyla, p<0.001; p=0.004) yaşam kalitesi ile ilişkili olduğu, ancak fiziksel semptomların emosyonel yaşam kalitesi (p=0.156) ile anlamlı bir ilişki göstermediği bulundu. Kalp yetersizliği hastalarında semptom prevalansı ve yükü yüksektir ve fiziksel ile psikolojik semptomlar total yaşam kalitesi ile önemli derecede ilişkilidir. Öz bakım ve diğer uygulama stratejilerinin kullanılması, semptomların iyileşmesine ve yaşam kalitesi ile diğer hasta sonuçlarının gelişmesine yol açabilir.

🔖

Cite This Article

Irmak, Z., Doğan, V., Başaran, Ö., Uysal, D. D., Mandaş, Ü. (2026). Heart Failure Symptoms and the Relationship Between the Symptoms and Quality of Life: A Cross-Sectional, Correlational Study. Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, Volume: 13 Issue: 1. https://doi.org/10.47572/muskutd.1666897

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (36)

  1. McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599-3726.
  2. Savarese G, Becher PM, Lund LH, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118:3272-3287.
  3. Celik A, Ural D, Sahin A, et al. Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study. Lancet Reg Health Eur. 2023;33:100723.
  4. Heo S, Moser DK, Lennie TA, et al. Changes in heart failure symptoms are associated with changes in health-related quality of life over 12 months. J Cardiovasc Nurs. 2018;33:460-466.
  5. Hu D, Liu J, Zhang L, et al. Health status predicts short- and long-term risk of composite clinical outcomes in acute heart failure. JACC Heart Fail. 2021;9:861-873.
  6. Wu JR, Moser DK. Health-related quality of life is a mediator of the relationship between medication adherence and cardiac event-free survival in heart failure. J Card Fail. 2021;27:848-856.
  7. Baert A, Smedt DD, Sutter JD, et al. Factors associated with health-related quality of life in stable ambulatory congestive heart failure patients: a systematic review. Eur J Prev Cardiol. 2018;25:472-481.
  8. Heo S, Lennie TA, Moser DK, et al. Testing of a health-related quality of life model in patients with heart failure: a cross-sectional study. Geriatr Nurs. 2022;44:105-111.
  9. Wang G, Liu X, Yang Q. Symptom clusters and quality of life in Chinese patients with heart failure. Collegian. 2020;27:521-528.
  10. Alemoush RA, Al-Dweik G, AbuRuz ME. The effect of persistent anxiety and depressive symptoms on quality of life among patients with heart failure. Appl Nurs Res. 2021;62:151503.
  11. Lin CY, Hammash M, Mudd-Martin G, et al. Older and younger patients’ perceptions and responses to worsening heart failure symptoms. Heart Lung. 2021;50:640-647.
  12. Salyer J, Flattery M, Lyon DE. Heart failure symptom clusters and quality of life. Heart Lung. 2019;48:366-372.
  13. Lokker ME, Gwyther L, Riley JP, et al. Prevalence and distress of physical and psychological symptoms in advanced heart failure. J Cardiovasc Nurs. 2016;31:313-322.
  14. Jering K, Claggett B, Redfield MM, et al. Burden of heart failure signs and symptoms, prognosis, and response to therapy: the PARAGON-HF trial. JACC Heart Fail. 2021;9:386-397.
  15. Gathright EC, Goldstein CM, Josephson RA, et al. Depression increases mortality risk in patients with heart failure: a meta-analysis. J Psychosom Res. 2017;99:82-89.
  16. Sokoreli I, Pauws SC, Steyerberg EW, et al. Prognostic value of psychosocial factors for hospitalizations and mortality in heart failure: OPERA-HF study. Eur J Heart Fail. 2018;20:689-696.
  17. Polikandrioti M, Kalafatakis F, Koutelekos I, et al. Fatigue in heart failure outpatients: levels, associated factors, and impact on quality of life. Arch Med Sci Atheroscler Dis. 2019;4:e103-e112.
  18. Johansson I, Joseph P, Balasubramanian K, et al. Health-related quality of life and mortality in heart failure: global study. Circulation. 2021;143:2129-2142.
  19. Kayhan SA, Nural N. Evaluation of symptoms and predictors in patients with heart failure in Turkey. J Hosp Palliat Nurs. 2017;19:404-412.
  20. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure Questionnaire. Am Heart J. 1992;124:1017-1025.
  21. Aşık Özdemir V. Kronik kalp yetmezliği olan hastalarda yaşam kalitesinin değerlendirilmesi. Yüksek lisans tezi. Marmara Üniversitesi; 2009.
  22. Zambroski CH, Moser DK, Bhat G, et al. Impact of symptom burden on quality of life in heart failure. Eur J Cardiovasc Nurs. 2005;4:198-206.
  23. Hwang SL, Liao WC, Huang TY. Predictors of quality of life in patients with heart failure. Jpn J Nurs Sci. 2014;11:290-298.
  24. Yao Q, Luo J, Song B, et al. Effect of heart failure symptom clusters on quality of life: moderating role of self-care behaviours. J Clin Nurs. 2025;34:2766-2778.
  25. Hu Y, Jiang J, Xu L, et al. Symptom clusters and quality of life among patients with chronic heart failure. Jpn J Nurs Sci. 2021;18:e12366.
  26. Youn-Jung S, Mi Hwa W. Symptom clusters and hospital readmission in heart failure. Res Theory Nurs Pract. 2018;32:311-317.
  27. Candemir M, Kızıltunç E, Nurkoç SG, et al. Predictors of hospital stay and adverse events in acute heart failure. Hellenic J Cardiol. 2024;24:1-10.
  28. Seckin M, Petrie MC, Stewart S, et al. Breathlessness and its management in Turkish individuals with heart failure. BMJ Open. 2024;14:e088335.
  29. Karı A, Özer Ö. Türkiye’de sağlık hizmetleri kaynaklarının ve sonuçlarının bölgesel karşılaştırılması. DÜİİBFD. 2020;10:331-350.
  30. Karabulut D, Günay Ş, Sert Şekerci S, et al. Heart failure awareness survey in a Turkish population: HFAS-TR. Turk Kardiyol Dern Ars. 2024;52:337-343.
  31. Özlek B, Özlek E, Ağuş HZ, et al. Clinical characteristics of HFpEF and HFmrEF in Turkey. Eur J Intern Med. 2019;61:88-95.
  32. Kocabaş U, Kıvrak T, Yılmaz Öztekin GM, et al. Adherence to guideline-directed therapy in heart failure: ATA study. Anatol J Cardiol. 2020;24:32-40.
  33. Chen C, Fang W, An Y, et al. Mediating effects of illness perception and coping in heart failure. Eur J Cardiovasc Nurs. 2020;19:125-133.
  34. Denfeld QE, Bidwell JT, Gelow JM, et al. Symptom clusters and 180-day event-free survival in heart failure. Heart Lung. 2020;49:151-157.
  35. Jonkman NH, Westland H, Groenwold RH, et al. Self-management interventions in heart failure: meta-analysis. Circulation. 2016;133:1189-1198.
  36. Jaarsma T, Hill L, Bayes-Genis A, et al. Self-care of heart failure patients: practical recommendations. Eur J Heart Fail. 2021;23:157-174.